<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30114981</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1544-2217</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Veterinary pathology</Title>                <ISOAbbreviation>Vet. Pathol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Estrogen Receptor-α and Progesterone Receptor Expression in Mammary Proliferative Lesions of Female Pet Rabbits.</ArticleTitle>            <Pagination>                <MedlinePgn>300985818788611</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1177/0300985818788611</ELocationID>            <Abstract>                <AbstractText>In breast cancer of women, the estrogen receptor-α (ERα) and progesterone receptor (PR) status has prognostic and therapeutic significance. The aim of this study was (1) to characterize by immunohistochemistry the expression of ERα and PR in nonneoplastic and neoplastic mammary gland tissue of pet rabbits and (2) to correlate the ERα/PR status and histological features. All 124 rabbits included in this study had a mammary tumor; in addition, 2 rabbits had lobular hyperplasia and 25 had multiple cysts. Of the 124 neoplasms, 119 (96%) were carcinoma, 2 (2%) were carcinoma in situ, and 3 (2%) were adenoma. ERα or PR or both were detected in 2 of 2 carcinomas in situ, 3 of 3 adenomas, 19 of 25 cysts, and 2 of 2 lesions of lobular hyperplasia. Most carcinomas (75/119, 63%) were negative for both ERα and PR; 22 of 119 carcinomas (18%) were double-immunopositive. The ERα and PR expression was not influenced by histotype or histological tumor grade. In carcinomas, there was a statistically significant correlation between increased mitotic count and reduced expression of ERα and PR, and the mitotic count was higher in double-immunonegative carcinomas (75/119). The findings suggest that in rabbit mammary carcinomas, proliferative activity is mainly influenced by factors other than estrogen and progesterone and provides the basis for future investigations into the prognostic significance of the ERα and PR status of mammary tumors.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Degner</LastName>                    <ForeName>Sophie</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>1 Institute of Veterinary Pathology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schoon</LastName>                    <ForeName>Heinz-Adolf</ForeName>                    <Initials>HA</Initials>                    <AffiliationInfo>                        <Affiliation>1 Institute of Veterinary Pathology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Laik-Schandelmaier</LastName>                    <ForeName>Claudia</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>2 Laboklin GmbH &amp; Co. KG, Bad Kissingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aupperle-Lellbach</LastName>                    <ForeName>Heike</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>2 Laboklin GmbH &amp; Co. KG, Bad Kissingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schöniger</LastName>                    <ForeName>Sandra</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>1 Institute of Veterinary Pathology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Vet Pathol</MedlineTA>            <NlmUniqueID>0312020</NlmUniqueID>            <ISSNLinking>0300-9858</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">estrogen receptor</Keyword>            <Keyword MajorTopicYN="N">histopathology</Keyword>            <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>            <Keyword MajorTopicYN="N">mammary carcinoma</Keyword>            <Keyword MajorTopicYN="N">mammary hyperplasia/dysplasia</Keyword>            <Keyword MajorTopicYN="N">progesterone receptor</Keyword>            <Keyword MajorTopicYN="N">rabbits</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30114981</ArticleId>            <ArticleId IdType="doi">10.1177/0300985818788611</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>